DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Onesource Specialty Pharma Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·3 Nov 2026, 8:03 am

Onesource Specialty Pharma

Onesource Specialty Pharma Limited has announced that the transcript from its earnings conference call held on October 27, 2026, is now available. This update allows investors to review the detailed discussion regarding the company's recent financial performance and future strategy.

For retail investors, this document provides transparency into management's outlook, which is crucial for assessing the company's growth trajectory. It helps investors understand the rationale behind recent results and upcoming plans, aiding in more informed decision-making.

Investors should focus on management's commentary regarding market trends, operational efficiency, and guidance for the upcoming quarters to gauge the company's potential.